Literature DB >> 24912896

Aprepitant versus dexamethasone to prevent delayed emesis after chemotherapy.

Terry L Ng1, Mark Clemons2, Brian Hutton3, George Dranistaris2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24912896     DOI： 10.1200/JCO.2014.55.3503

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Chemotherapy-Induced Nausea and Vomiting: Time for More Emphasis on Nausea?

Authors:  Terry L Ng; Brian Hutton; Mark Clemons
Journal:  Oncologist       Date:  2015-05-06

2.  Defining optimal control of chemotherapy-induced nausea and vomiting-based on patients' experience.

Authors:  Catalina Hernandez Torres; Sasha Mazzarello; Terry Ng; George Dranitsaris; Brian Hutton; Stephanie Smith; Amy Munro; Carmel Jacobs; Mark Clemons
Journal:  Support Care Cancer       Date:  2015-06-25       Impact factor: 3.603

3.  Clinical predictors of anticipatory emesis in patients treated with chemotherapy at a tertiary care cancer hospital.

Authors:  Fawad Qureshi; Azhar Shafi; Sheeraz Ali; Neelam Siddiqui
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

4.  A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting.

Authors:  M Clemons; G Dranitsaris; M Sienkiewicz; S Sehdev; T Ng; A Robinson; M Mates; T Hsu; S McGee; O Freedman; V Kumar; D Fergusson; B Hutton; L Vandermeer; J Hilton
Journal:  Breast       Date:  2020-11-10       Impact factor: 4.380
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.